Management  ||| S:0 E:11 ||| NN
of  ||| S:11 E:14 ||| IN
infants  ||| S:14 E:22 ||| NNS
with  ||| S:22 E:27 ||| IN
cystic  ||| S:27 E:34 ||| JJ
fibrosis ||| S:34 E:42 ||| NN
:  ||| S:42 E:44 ||| :
a  ||| S:44 E:46 ||| DT
summary  ||| S:46 E:54 ||| NN
of  ||| S:54 E:57 ||| IN
the  ||| S:57 E:61 ||| DT
evidence  ||| S:61 E:70 ||| NN
for  ||| S:70 E:74 ||| IN
the  ||| S:74 E:78 ||| DT
cystic  ||| S:78 E:85 ||| JJ
fibrosis  ||| S:85 E:94 ||| JJ
foundation  ||| S:94 E:105 ||| NN
working  ||| S:105 E:113 ||| VBG
group  ||| S:113 E:119 ||| NN
on  ||| S:119 E:122 ||| IN
care  ||| S:122 E:127 ||| NN
of  ||| S:127 E:130 ||| IN
infants  ||| S:130 E:138 ||| NNS
with  ||| S:138 E:143 ||| IN
cystic  ||| S:143 E:150 ||| JJ
fibrosis  ||| S:150 E:159 ||| NN
To  ||| S:159 E:162 ||| TO
inform  ||| S:162 E:169 ||| VB
the  ||| S:169 E:173 ||| DT
development  ||| S:173 E:185 ||| NN
of  ||| S:185 E:188 ||| IN
Cystic  ||| S:188 E:195 ||| NNP
Fibrosis  ||| S:195 E:204 ||| NNP
( ||| S:204 E:205 ||| -LRB-
CF ||| S:205 E:207 ||| NNP
)  ||| S:207 E:209 ||| -RRB-
Foundation  ||| S:209 E:220 ||| NNP
guidelines  ||| S:220 E:231 ||| NNS
on  ||| S:231 E:234 ||| IN
the  ||| S:234 E:238 ||| DT
care  ||| S:238 E:243 ||| NN
of  ||| S:243 E:246 ||| IN
infants  ||| S:246 E:254 ||| NNS
with  ||| S:254 E:259 ||| IN
CF ||| S:259 E:261 ||| NNP
,  ||| S:261 E:263 ||| ,
we  ||| S:263 E:266 ||| PRP
systematically  ||| S:266 E:281 ||| VBP
reviewed  ||| S:281 E:290 ||| VBN
the  ||| S:290 E:294 ||| DT
evidence  ||| S:294 E:303 ||| NN
for  ||| S:303 E:307 ||| IN
diagnosis  ||| S:307 E:317 ||| NN
and  ||| S:317 E:321 ||| CC
assessment  ||| S:321 E:332 ||| NN
of  ||| S:332 E:335 ||| IN
pancreatic  ||| S:335 E:346 ||| NN
and  ||| S:346 E:350 ||| CC
pulmonary  ||| S:350 E:360 ||| JJ
disorders ||| S:360 E:369 ||| NNS
;  ||| S:369 E:371 ||| :
management  ||| S:371 E:382 ||| NN
of  ||| S:382 E:385 ||| IN
pancreatic  ||| S:385 E:396 ||| NN
and  ||| S:396 E:400 ||| CC
pulmonary  ||| S:400 E:410 ||| JJ
function ||| S:410 E:418 ||| NN
;  ||| S:418 E:420 ||| :
management  ||| S:420 E:431 ||| NN
of  ||| S:431 E:434 ||| IN
nutrition  ||| S:434 E:444 ||| NN
and  ||| S:444 E:448 ||| CC
nutritional  ||| S:448 E:460 ||| JJ
disorders ||| S:460 E:469 ||| NNS
;  ||| S:469 E:471 ||| :
and  ||| S:471 E:475 ||| CC
prevention  ||| S:475 E:486 ||| NN
and  ||| S:486 E:490 ||| CC
control  ||| S:490 E:498 ||| NN
of  ||| S:498 E:501 ||| IN
infections ||| S:501 E:511 ||| NNS
.  ||| S:511 E:513 ||| .
In  ||| S:513 E:516 ||| IN
May-June  ||| S:516 E:525 ||| JJ
2008 ||| S:525 E:529 ||| CD
,  ||| S:529 E:531 ||| ,
we  ||| S:531 E:534 ||| PRP
searched  ||| S:534 E:543 ||| VBD
The  ||| S:543 E:547 ||| DT
Cochrane  ||| S:547 E:556 ||| NNP
Library  ||| S:556 E:564 ||| NNP
for  ||| S:564 E:568 ||| IN
existing  ||| S:568 E:577 ||| VBG
reviews ||| S:577 E:584 ||| NNS
;  ||| S:584 E:586 ||| :
and  ||| S:586 E:590 ||| CC
MEDLINE ||| S:590 E:597 ||| NNP
,  ||| S:597 E:599 ||| ,
the  ||| S:599 E:603 ||| DT
National  ||| S:603 E:612 ||| NNP
Guideline  ||| S:612 E:622 ||| NNP
Clearinghouse ||| S:622 E:635 ||| NNP
,  ||| S:635 E:637 ||| ,
the  ||| S:637 E:641 ||| DT
CF  ||| S:641 E:644 ||| NNP
Foundation  ||| S:644 E:655 ||| NNP
Clinical  ||| S:655 E:664 ||| NNP
Practice  ||| S:664 E:673 ||| NNP
Guidelines  ||| S:673 E:684 ||| NNP
and  ||| S:684 E:688 ||| CC
Consensus  ||| S:688 E:698 ||| NNP
Statements ||| S:698 E:708 ||| NNP
,  ||| S:708 E:710 ||| ,
and  ||| S:710 E:714 ||| CC
the  ||| S:714 E:718 ||| DT
UK  ||| S:718 E:721 ||| NNP
CF  ||| S:721 E:724 ||| NNP
Trust  ||| S:724 E:730 ||| NNP
for  ||| S:730 E:734 ||| IN
existing  ||| S:734 E:743 ||| VBG
guidelines ||| S:743 E:753 ||| NNS
.  ||| S:753 E:755 ||| .
MEDLINE ||| S:755 E:762 ||| NNP
,  ||| S:762 E:764 ||| ,
Cumulative  ||| S:764 E:775 ||| NNP
Index  ||| S:775 E:781 ||| NNP
to  ||| S:781 E:784 ||| TO
Nursing  ||| S:784 E:792 ||| NNP
and  ||| S:792 E:796 ||| CC
Allied  ||| S:796 E:803 ||| NNP
Health  ||| S:803 E:810 ||| NNP
Literature  ||| S:810 E:821 ||| NNP
( ||| S:821 E:822 ||| -LRB-
CINAHL ||| S:822 E:828 ||| NNP
)  ||| S:828 E:830 ||| -RRB-
and  ||| S:830 E:834 ||| CC
the  ||| S:834 E:838 ||| DT
Excerpta  ||| S:838 E:847 ||| NNP
Medica  ||| S:847 E:854 ||| NNP
Database  ||| S:854 E:863 ||| NNP
( ||| S:863 E:864 ||| -LRB-
EMBASE ||| S:864 E:870 ||| NNP
)  ||| S:870 E:872 ||| -RRB-
were  ||| S:872 E:877 ||| VBD
searched  ||| S:877 E:886 ||| VBN
for  ||| S:886 E:890 ||| IN
primary  ||| S:890 E:898 ||| JJ
studies  ||| S:898 E:906 ||| NNS
in  ||| S:906 E:909 ||| IN
January  ||| S:909 E:917 ||| NNP
2008 ||| S:917 E:921 ||| CD
.  ||| S:921 E:923 ||| .
Bibliographies  ||| S:923 E:938 ||| NNP
of  ||| S:938 E:941 ||| IN
eligible  ||| S:941 E:950 ||| JJ
articles  ||| S:950 E:959 ||| NNS
were  ||| S:959 E:964 ||| VBD
searched  ||| S:964 E:973 ||| JJ
and  ||| S:973 E:977 ||| CC
expert  ||| S:977 E:984 ||| NN
input  ||| S:984 E:990 ||| NN
was  ||| S:990 E:994 ||| VBD
sought ||| S:994 E:1000 ||| VBN
.  ||| S:1000 E:1002 ||| .
We  ||| S:1002 E:1005 ||| PRP
selected  ||| S:1005 E:1014 ||| VBD
English-language  ||| S:1014 E:1031 ||| JJ
articles  ||| S:1031 E:1040 ||| NNS
of  ||| S:1040 E:1043 ||| IN
any  ||| S:1043 E:1047 ||| DT
study  ||| S:1047 E:1053 ||| NN
design  ||| S:1053 E:1060 ||| NN
that  ||| S:1060 E:1065 ||| WDT
provided  ||| S:1065 E:1074 ||| VBD
original  ||| S:1074 E:1083 ||| JJ
data  ||| S:1083 E:1088 ||| NNS
on  ||| S:1088 E:1091 ||| IN
any  ||| S:1091 E:1095 ||| DT
of  ||| S:1095 E:1098 ||| IN
our  ||| S:1098 E:1102 ||| PRP$
questions  ||| S:1102 E:1112 ||| NNS
on  ||| S:1112 E:1115 ||| IN
infants  ||| S:1115 E:1123 ||| VBG
up  ||| S:1123 E:1126 ||| RP
to  ||| S:1126 E:1129 ||| TO
2  ||| S:1129 E:1131 ||| CD
years  ||| S:1131 E:1137 ||| NNS
of  ||| S:1137 E:1140 ||| IN
age ||| S:1140 E:1143 ||| NN
.  ||| S:1143 E:1145 ||| .
We  ||| S:1145 E:1148 ||| PRP
identified  ||| S:1148 E:1159 ||| VBD
14  ||| S:1159 E:1162 ||| CD
relevant  ||| S:1162 E:1171 ||| JJ
guidelines  ||| S:1171 E:1182 ||| NNS
and  ||| S:1182 E:1186 ||| CC
3  ||| S:1186 E:1188 ||| CD
Cochrane  ||| S:1188 E:1197 ||| JJ
reviews ||| S:1197 E:1204 ||| NNS
.  ||| S:1204 E:1206 ||| .
Fifty-nine  ||| S:1206 E:1217 ||| JJ
articles  ||| S:1217 E:1226 ||| NNS
( ||| S:1226 E:1227 ||| -LRB-
55  ||| S:1227 E:1230 ||| CD
primary  ||| S:1230 E:1238 ||| JJ
studies ||| S:1238 E:1245 ||| NNS
)  ||| S:1245 E:1247 ||| -RRB-
were  ||| S:1247 E:1252 ||| VBD
included ||| S:1252 E:1260 ||| VBN
.  ||| S:1260 E:1262 ||| .
Only  ||| S:1262 E:1267 ||| RB
four  ||| S:1267 E:1272 ||| CD
of  ||| S:1272 E:1275 ||| IN
these  ||| S:1275 E:1281 ||| DT
were  ||| S:1281 E:1286 ||| VBD
randomized  ||| S:1286 E:1297 ||| VBN
controlled  ||| S:1297 E:1308 ||| VBN
trials ||| S:1308 E:1314 ||| NNS
.  ||| S:1314 E:1316 ||| .
Sample  ||| S:1316 E:1323 ||| NN
sizes  ||| S:1323 E:1329 ||| NNS
of  ||| S:1329 E:1332 ||| IN
infants  ||| S:1332 E:1340 ||| NNS
ranged  ||| S:1340 E:1347 ||| VBD
from  ||| S:1347 E:1352 ||| IN
2  ||| S:1352 E:1354 ||| CD
to  ||| S:1354 E:1357 ||| TO
768  ||| S:1357 E:1361 ||| CD
study  ||| S:1361 E:1367 ||| NN
participants ||| S:1367 E:1379 ||| NNS
;  ||| S:1379 E:1381 ||| :
the  ||| S:1381 E:1385 ||| DT
median  ||| S:1385 E:1392 ||| JJ
sample  ||| S:1392 E:1399 ||| NN
size  ||| S:1399 E:1404 ||| NN
was  ||| S:1404 E:1408 ||| VBD
24 ||| S:1408 E:1410 ||| CD
.  ||| S:1410 E:1412 ||| .
Of  ||| S:1412 E:1415 ||| IN
our  ||| S:1415 E:1419 ||| PRP$
21  ||| S:1419 E:1422 ||| CD
review  ||| S:1422 E:1429 ||| NN
topics ||| S:1429 E:1435 ||| NNS
,  ||| S:1435 E:1437 ||| ,
5  ||| S:1437 E:1439 ||| CD
topics  ||| S:1439 E:1446 ||| NNS
had  ||| S:1446 E:1450 ||| VBD
only  ||| S:1450 E:1455 ||| RB
one  ||| S:1455 E:1459 ||| CD
study  ||| S:1459 E:1465 ||| NN
while  ||| S:1465 E:1471 ||| IN
for  ||| S:1471 E:1475 ||| IN
5  ||| S:1475 E:1477 ||| CD
we  ||| S:1477 E:1480 ||| PRP
identified  ||| S:1480 E:1491 ||| VBD
no  ||| S:1491 E:1494 ||| DT
relevant  ||| S:1494 E:1503 ||| JJ
studies ||| S:1503 E:1510 ||| NNS
.  ||| S:1510 E:1512 ||| .
We  ||| S:1512 E:1515 ||| PRP
identified  ||| S:1515 E:1526 ||| VBD
one  ||| S:1526 E:1530 ||| CD
or  ||| S:1530 E:1533 ||| CC
no  ||| S:1533 E:1536 ||| DT
primary  ||| S:1536 E:1544 ||| JJ
studies  ||| S:1544 E:1552 ||| NNS
for  ||| S:1552 E:1556 ||| IN
20  ||| S:1556 E:1559 ||| CD
of  ||| S:1559 E:1562 ||| IN
32  ||| S:1562 E:1565 ||| CD
review  ||| S:1565 E:1572 ||| NN
questions ||| S:1572 E:1581 ||| NNS
.  ||| S:1581 E:1583 ||| .
There  ||| S:1583 E:1589 ||| EX
is  ||| S:1589 E:1592 ||| VBZ
a  ||| S:1592 E:1594 ||| DT
paucity  ||| S:1594 E:1602 ||| NN
of  ||| S:1602 E:1605 ||| IN
evidence  ||| S:1605 E:1614 ||| NN
on  ||| S:1614 E:1617 ||| IN
the  ||| S:1617 E:1621 ||| DT
care  ||| S:1621 E:1626 ||| NN
of  ||| S:1626 E:1629 ||| IN
infants  ||| S:1629 E:1637 ||| NNS
diagnosed  ||| S:1637 E:1647 ||| VBN
with  ||| S:1647 E:1652 ||| IN
CF ||| S:1652 E:1654 ||| NNP
.  ||| S:1654 E:1656 ||| .
For  ||| S:1656 E:1660 ||| IN
several  ||| S:1660 E:1668 ||| JJ
of  ||| S:1668 E:1671 ||| IN
the  ||| S:1671 E:1675 ||| DT
review  ||| S:1675 E:1682 ||| NN
questions  ||| S:1682 E:1692 ||| NNS
no  ||| S:1692 E:1695 ||| DT
guidelines  ||| S:1695 E:1706 ||| NNS
or  ||| S:1706 E:1709 ||| CC
primary  ||| S:1709 E:1717 ||| JJ
studies  ||| S:1717 E:1725 ||| NNS
were  ||| S:1725 E:1730 ||| VBD
identified ||| S:1730 E:1740 ||| VBN
,  ||| S:1740 E:1742 ||| ,
but  ||| S:1742 E:1746 ||| CC
for  ||| S:1746 E:1750 ||| IN
other  ||| S:1750 E:1756 ||| JJ
questions ||| S:1756 E:1765 ||| NNS
,  ||| S:1765 E:1767 ||| ,
studies  ||| S:1767 E:1775 ||| NNS
limited  ||| S:1775 E:1783 ||| VBN
by  ||| S:1783 E:1786 ||| IN
weak  ||| S:1786 E:1791 ||| JJ
design  ||| S:1791 E:1798 ||| NN
and  ||| S:1798 E:1802 ||| CC
small  ||| S:1802 E:1808 ||| JJ
sample  ||| S:1808 E:1815 ||| NN
sizes  ||| S:1815 E:1821 ||| NNS
were  ||| S:1821 E:1826 ||| VBD
the  ||| S:1826 E:1830 ||| DT
only  ||| S:1830 E:1835 ||| JJ
studies  ||| S:1835 E:1843 ||| NNS
identified ||| S:1843 E:1853 ||| VBN
.  ||| S:1853 E:1855 ||| .
With  ||| S:1855 E:1860 ||| IN
increasing  ||| S:1860 E:1871 ||| VBG
numbers  ||| S:1871 E:1879 ||| NNS
of  ||| S:1879 E:1882 ||| IN
infants  ||| S:1882 E:1890 ||| NNS
with  ||| S:1890 E:1895 ||| IN
CF  ||| S:1895 E:1898 ||| NNP
being  ||| S:1898 E:1904 ||| VBG
diagnosed  ||| S:1904 E:1914 ||| VBN
by  ||| S:1914 E:1917 ||| IN
newborn  ||| S:1917 E:1925 ||| JJ
screening  ||| S:1925 E:1935 ||| NN
there  ||| S:1935 E:1941 ||| EX
is  ||| S:1941 E:1944 ||| VBZ
an  ||| S:1944 E:1947 ||| DT
opportunity  ||| S:1947 E:1959 ||| NN
to  ||| S:1959 E:1962 ||| TO
study  ||| S:1962 E:1968 ||| VB
the  ||| S:1968 E:1972 ||| DT
management  ||| S:1972 E:1983 ||| NN
of  ||| S:1983 E:1986 ||| IN
infants  ||| S:1986 E:1994 ||| NNS
diagnosed  ||| S:1994 E:2004 ||| VBN
with  ||| S:2004 E:2009 ||| IN
CF ||| S:2009 E:2011 ||| NNP
.  ||| S:2011 E:2013 ||| .
